Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Desferrioxamine Mesylate for Managing Transfusional Iron Overload in People With Transfusion‐dependent Thalassaemia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431374/all/Desferrioxamine_mesylate_for_managing_transfusional_iron_overload_in_people_with_transfusion‐dependent_thalassaemia.
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431374/all/Desferrioxamine_mesylate_for_managing_transfusional_iron_overload_in_people_with_transfusion‐dependent_thalassaemia. Accessed February 10, 2025.
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431374/all/Desferrioxamine_mesylate_for_managing_transfusional_iron_overload_in_people_with_transfusion‐dependent_thalassaemia
Desferrioxamine Mesylate for Managing Transfusional Iron Overload in People With Transfusion‐dependent Thalassaemia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431374/all/Desferrioxamine_mesylate_for_managing_transfusional_iron_overload_in_people_with_transfusion‐dependent_thalassaemia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia
ID - 431374
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431374/all/Desferrioxamine_mesylate_for_managing_transfusional_iron_overload_in_people_with_transfusion‐dependent_thalassaemia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -